Table 5.
Univariate and multivariable logistic regression models for post-TAVR myocardial injury adjusted for pre-dilatation, post-dilatation, and rapid pacing
Predictor | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
OR | 95% CI | p value | OR | 95% CI | p value | |
Sex (male) | 0.56 | 0.37–0.82 | 0.390 | 0.76 | 0.46–1.26 | 0.283 |
Age | 1.01 | 0.98–1.05 | 0.466 | 0.97 | 0.92–1.01 | 0.156 |
SEV | 2.52 | 1.62–4.05 | < 0.001 | 2.99 | 1.59–5.99 | 0.001 |
Pre-TAVR CrCl | 0.99 | 0.98–1.00 | 0.031 | 0.98 | 0.97–1.00 | 0.015 |
LVEF | 1.03 | 1.01–1.05 | < 0.001 | 1.05 | 1.02–1.07 | < 0.001 |
Diabetes | 0.57 | 0.38–0.87 | 0.009 | 0.74 | 0.45–1.24 | 0.244 |
CAD | 0.58 | 0.39–0.86 | 0.007 | 0.76 | 0.46–1.25 | 0.280 |
Maximum aortic gradient | 1.01 | 1.00–1.02 | 0.014 | 1.01 | 1.00–1.02 | 0.178 |
Pre-dilatation | 1.24 | 0.82–1.86 | 0.312 | 1.04 | 0.63–1.73 | 0.867 |
Post-dilatation | 1.09 | 0.56–2.28 | 0.809 | 0.87 | 0.41–1.99 | 0.729 |
Rapid pacing | 0.65 | 0.34–1.15 | 0.158 | 1.37 | 0.58–3.24 | 0.469 |
CAD coronary artery disease, CrCl creatinine clearance, LVEF left ventricular ejection fraction, SEV self-expandable valve, TAVR transcatheter aortic valve replacement